Latest News and Press Releases
Want to stay updated on the latest news?
-
Today, Biocartis announced that it has entered into a research collaboration with the Medical College of Wisconsin (MCW).
-
PRESS RELEASE 10/03/2025, 08:00 CET Biocartis Receives European IVDR Certification for the Idylla™ CDx MSI Test Idylla™ CDx MSI Test is the Second Fully Automated Companion Diagnostic Test Approval...
-
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Hub Group To Contact Him Directly To Discuss Their Options If you...
-
Austin, TX, USA, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Life Insurance Policy Administration Systems Market Size, Trends and Insights By...
-
PRESS RELEASE, 01/12/2026, 10:00 EST Biocartis to collaborate with Mayo Clinic on breast cancer gene signatures Itasca, IL, US, 12 January 2026 – Biocartis announced today that it has entered into a...
-
PRESS RELEASE, 11/14/2025, 10:00 AM EST Biocartis Showcases Growing Impact of Idylla™ Platform at AMP 2025 Multiple abstracts and a corporate workshop highlight Idylla™’s growing role in oncology...
-
The Breakthrough Women series announces the October 4th premiere of an inspiring episode during Breast Cancer Awareness Month featuring Dr. Carey K. Anders
-
PRESS RELEASE - 09/15/2025, 09:00 AM EDT Biocartis Receives FDA Approval for the Idylla™ CDx MSI Test First-ever fully automated, sample-to-result, cartridge-based companion diagnostic test approved...
-
PRESS RELEASE - 08/18/2025, 09:00 AM EDT Biocartis Welcomes Mike Kreitzinger as Senior Vice President of Global Business Development Itasca (IL), United States, August 18th, 2025 – Biocartis Group...
-
Dublin, Aug. 11, 2025 (GLOBE NEWSWIRE) -- The "Biocartis Group NV (BCART) - Product Pipeline Analysis, 2025 Update" has been added to ResearchAndMarkets.com's offering. Biocartis Group NV is a...